Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection

Rehabilitation Required Due to Functional Neurological Impairment and Respiratory Disorders After Severe SARS-CoV-2 Infection in ICU Units

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04681755

Acronym

REHABCOV

Enrollment

Registered

2020-12-23

Start date

2020-05-19

Completion date

2021-05-19

Last updated

2020-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

Rehabilitation, SARS-CoV-2, COVID-19, Neurological function, Respiratory disorder, Intensive care unit

Brief summary

Due to the emergence of an epidemic cluster in Mulhouse, a city located 100 km south of Strasbourg, Alsace was one of the first French regions to be affected by the coronavirus (SARS-CoV-2 or COVID-19). As a result, all hospitals in the region, including both Strasbourg University Hospitals, had to deal with the epidemic wave earlier and more intensely than the rest of France. At the time of writing this article, 6 weeks after the start of the epidemic, we have counted 998 hospital deaths in our region, i.e., an intrahospital mortality rate linked to COVID-19 of 5.3 deaths per 10,000 inhabitants (https://dashboard.covid19.data.gouv.fr/). Currently, our intensive care unit still has a large number of patients hospitalized for COVID-19. Some of these patients have severe damage to one or more organs, and in particular a neurological or respiratory deficit suggesting that they will need post-resuscitation rehabilitation. The primary aim is to assess the neurological disorder after severe SARS-CoV-2 infection and the second is the respiratory impairment evaluation.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patient (≥18 years old) * Patient hospitalized in surgical intensive care at the New Civil Hospital between February 24 and April 15, 2020. * Patient with a SARS-CoV-2 infection documented by RT-PCR or with lesions suggestive on chest CT. * Patient who has given his consent for the use of his data for the purposes of this research

Exclusion criteria

* Patient without documentation of SARS-CoV-2 infection (RT-PCR or chest scanner) * Patient who expressed his opposition to participating in the study * Subject under safeguard of justice * Subject under guardianship or guardianship

Design outcomes

Primary

Measure	Time frame
Retrospective analysis of the neurological disorder after severe SARS-CoV-2 infection	The files analysed retrospectily from February 24, 2020 to April 15, 2020 will be examined]

Countries

France

Contacts

Primary ContactWalid Oulehri, MD

walid.oulehri@chru-strasbourg.fr33 3 69 55 12 71

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results